The untapped solid tumour market is worth US$400bn+ in the next few years. Just 5% of that market will equal US$20bn+ annually. Less humongous cost of 50% leaves gross profit of US$10bn. At PE of just 15, IMU will have a market cap of US150bn. That is more than 100 bags of current market cap/share price.
And that above is based on very, very conservative assumptions. No wonder some one posted recently about an analyst valuing a cure for cancer at $50 trillion.
Meanwhile, IMU is going cheap at under 20 cents. Get them while it last, I say.
DYOR as above just my wild opinion only.
Media Thread, page-7198
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |